NY Center Investigator Development Core Pilot Project, “Exploring pathways of genetic risk in substance use disorders and comorbid medical problems”

Research Areas

  • Alcohol and substance use disorders
  • Comorbidity of psychiatric problems
  • Psychiatric genetics

Scientific Achievements

  • Reported epidemiological snapshot of psychiatric diagnoses in the All of Us Research Program.
  • One of the lead analysts on a large-scale exploration into the genetic overlap between substance use and impulse-related problems.
  • Publications:
    • doi: 10.64898/2026.01.19.26344398 (2026)
    • doi: 10.64898/2026.02.09.26344198 (2026)
    • doi: 10.1001/jamanetworkopen.2025.39313 (2025)
    • doi: 10.1101/2025.08.19.25332327 (2025)
    • doi: 10.1038/s41398-025-03454-9 (2025)

Funding

RCMI Funding:
  • U54MD017979 Pilot Project “Exploring pathways of genetic risk in substance use disorders and comorbid medical problems”
Other funding obtained with RCMI support:
  • R01DA061850 (mPI) “Neighborhood conditions, neural circuits, and substance use behaviors across the early life course”

Scientific Advance

Multivariate genetic analyses of 2.2 million individuals reveal broad and substance-specific pathways of addiction risk
Published in Nature Mental Health, Mar 20;4(4):582–593, 2026, PMCID: PMC13076202
Ongoing efforts to identify genes involved in substance use disorders (SUDs) often focus on individual disorders despite high rates of co-occurrence with each other and other externalizing traits. Here we investigate whether incorporating data on other externalizing traits can boost power to detect genetic signal without sacrificing specificity of SUD genetic signal. We used multivariate genomic analyses and downstream biological annotation and genetic association analyses to explore this question. We found that joint analysis of SUDs and other externalizing traits resulted in increased insights into the neurobiology of broad and substance-specific SUD risk. We found no evidence of loss of specificity for SUD genetic signal but note improvements in our ability to characterize the neurobiology of broad and substance-specific SUD genetic effects. Our findings suggest that genetic risk for SUDs operates largely via pathways shared with other behaviors characterized by behavioral disinhibition, with additional substance-specific risk, and that modeling this shared disposition improves gene discovery.
RCMI Funding: U54MD017979 Pilot Project Other funding obtained with RCMI support: R01DA061850 (mPI) “Neighborhood conditions, neural circuits, and substance use behaviors across the early life course”
Toggle Navigation